Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ADCS Prevention Instrument Project: the Mail-In Cognitive Function Screening Instrument (MCFSI).

Alzheimer disease and associated disorders - 1 Jan 2000

Walsh Sally P, Raman Rema, Jones Katherine B, Aisen Paul S

Abstract excerpt

In future research on the prevention of Alzheimer Disease (AD), a large simple prevention trial might test a safe intervention (eg, vitamins) in a very large population (eg, 10,000 subjects), powered to detect a modest treatment effect size. In a large, simple design, regular assessments must be very low cost, for example, handled by mail. The Mail-In Cognitive Function Screening Instrument (MCFSI) was developed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activities of Daily Living
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognition Disorders

Share to Mass Screening

Share to Neuropsychological Tests

Share to Primary Prevention

Share to Surveys and Questionnaires

Share to United States

Source

Identifiers

PMID: 17135810
DOI: 10.1097/01.wad.0000213879.55547.57

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

ADCS Prevention Instrument Project: the Mail-In Cognitive Function Screening Instrument (MCFSI).PMID 17135810Read ↗

Remote Digital Cognitive Assessment in a Trial-Ready Alzheimer’s Cohort: A Scalable Approach for Early Intervention StudiesSemantic proximity Read ↗

Measuring Subjective Cognitive Decline in Older Adults: Harmonization between the Cognitive Change Index and the Measurement of Everyday Cognition InstrumentsSemantic proximity Read ↗

Development of Novel Measures for Alzheimer’s Disease Prevention Trials (NoMAD)Semantic proximity Read ↗

The Value of Pre-Screening in the Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Trial.Semantic proximity Read ↗

Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer's Prevention Trial: A global Perspective from the API Generation Program.Semantic proximity Read ↗

The Physical Activity and Alzheimer's Disease (PAAD) Study: Cognitive outcomes.Semantic proximity Read ↗

GeneMatch: A novel recruitment registry using at‐home APOE genotyping to enhance referrals to Alzheimer's prevention studiesSemantic proximity Read ↗

Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.